Bionano Genomics, Inc. provided earnings guidance for the fourth quarter and Full year 2023. For the quarter, the company's revenues are expected to be in the range of $10.4 million to $10.7 million, an estimated increase of 27% to 30% compared to $8.2 million in the fourth quarter of 2022.

For the year, the company's revenue is expected to be in the range of $35.8 million and $36.1 million, an estimated increase of 29% to 30% compared to full year 2022.